Binh Thai - Thailand

“COVID test kits will need to undergo in-country validation as part of the Class 4 Licensing process in Thailand.”

Binh Thai
General Manager
Asia Actual Thailand

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Thai Requirements for COVID Test Kits

Published on: May 19th, 2021

Similar to other markets in the region, manufacturers of COVID test kits will need to undergo in-country validation as part of the Class 4 Licensing process in Thailand. Like all other medical devices under the new Thai rules, the Thai FDA may take approvals in other countries into account but does not currently have an expedited review route for COVID test products approved in other markets including reference countries. Depending on the type of test, validation fees will vary from 65,000 baht (US$2,200) up to 143,200 baht (US$4,800) and could take 1-4 months to complete. Once validation testing has been completed, manufacturers can then submit their License application through their local office or license holder which incurs a US$1,775)

Validation Requirements

Requirements vary depending on the type of test with sample requirements varying from 100-200 samples. Antigen tests will even require a local clinical trial. Along with lab fees, there will also be a 3,200 baht TFDA application fee applicable to all products.

  • Real Time RT-PCR tests will require 100 samples with lab fees not to exceed 100,000 baht (US$3,000). It is estimated that validation will require 30 working days plus the technology assessment (time required varies).
  • Antibody tests will require 200 samples with lab fees not to 140,000 baht (US$4,600). Validation timeline is currently about 75 days but does depend on the number of products in the queue.
  • Antigen tests will need to work with a local hospital to coordinate a clinical trial before being approved for sale in Thailand. The size, costs, and timelines will depend on the agreement made with the partner hospital plus 30 days for the TFDA’s review.

The TFDA has released a few guidance documents to help manufacturers better understand the process but are currently only available in Thai.

Come Grow With Us

Contact Asia Actual if you’d like to learn more about the regulatory process in Thailand or other markets in the region.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

collaborative initiative by Philippine Authorities will have far reaching benefits, not just for foreign and domestic medical device and pharmaceutical manufacturers but for the Filipino economy as well.

Philippines Incentivizing Local Medical Device Manufacturing

On March 14th, 2024, the Philippines FDA announced plans to accelerate medical device and pharma manufacturing through proposed ecozones.
Woman Scanning China UDI Medical Device after June 1st, 2024 Implementation

China’s Third Batch of UDI Implementation Deadline in June

Reminder that China NMPA's UDI implementation deadline is June 1st, 2024 after which all aforementioned devices must be labelled.
Most efficient TFDA application processing review time

Thai FDA Reduces Application Review Time

On February 21st, 2024 the TFDA provided data to show a reduction in application review times and increased accessibility with their digital service system.